These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23131748)

  • 1. Myelination: do astrocytes play a role?
    Barnett SC; Linington C
    Neuroscientist; 2013 Oct; 19(5):442-50. PubMed ID: 23131748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How factors secreted from astrocytes impact myelin repair.
    Moore CS; Abdullah SL; Brown A; Arulpragasam A; Crocker SJ
    J Neurosci Res; 2011 Jan; 89(1):13-21. PubMed ID: 20857501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin 43/47 channels are important for astrocyte/ oligodendrocyte cross-talk in myelination and demyelination.
    Basu R; Sarma JD
    J Biosci; 2018 Dec; 43(5):1055-1068. PubMed ID: 30541963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why does remyelination fail in multiple sclerosis?
    Franklin RJ
    Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adult oligodendrocytes in remyelination after neural injury.
    Vick RS; Neuberger TJ; DeVries GH
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S93-103. PubMed ID: 1588636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for CXCR2 and CXCL1 on glia in multiple sclerosis.
    Omari KM; John G; Lango R; Raine CS
    Glia; 2006 Jan; 53(1):24-31. PubMed ID: 16086366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes in multiple sclerosis.
    Ludwin SK; Rao VTs; Moore CS; Antel JP
    Mult Scler; 2016 Aug; 22(9):1114-24. PubMed ID: 27207458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ; Asakura K; Rodriguez M
    J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
    Kulbatski I; Mothe AJ; Parr AM; Kim H; Kang CE; Bozkurt G; Tator CH
    Prog Histochem Cytochem; 2008; 43(3):123-76. PubMed ID: 18706353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remyelination in demyelinating diseases of the central nervous system.
    Ludwin SK
    Crit Rev Neurobiol; 1987; 3(1):1-28. PubMed ID: 3552450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1).
    Moreels M; Vandenabeele F; Dumont D; Robben J; Lambrichts I
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):532-46. PubMed ID: 18005096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination.
    Seiwa C; Yamamoto M; Tanaka K; Fukutake M; Ueki T; Takeda S; Sakai R; Ishige A; Watanabe K; Akita M; Yagi T; Tanaka K; Asou H
    J Neurosci Res; 2007 Apr; 85(5):954-66. PubMed ID: 17290413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.
    Calzà L; Fernandez M; Giuliani A; D'Intino G; Pirondi S; Sivilia S; Paradisi M; Desordi N; Giardino L
    Brain Res Brain Res Rev; 2005 Apr; 48(2):339-46. PubMed ID: 15850672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis.
    Jadasz JJ; Aigner L; Rivera FJ; Küry P
    Cell Tissue Res; 2012 Jul; 349(1):331-47. PubMed ID: 22322424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes in multiple sclerosis: a product of their environment.
    Nair A; Frederick TJ; Miller SD
    Cell Mol Life Sci; 2008 Sep; 65(17):2702-20. PubMed ID: 18516496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination.
    Cheli VT; Correale J; Paez PM; Pasquini JM
    ASN Neuro; 2020; 12():1759091420962681. PubMed ID: 32993319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.
    Ponath G; Ramanan S; Mubarak M; Housley W; Lee S; Sahinkaya FR; Vortmeyer A; Raine CS; Pitt D
    Brain; 2017 Feb; 140(2):399-413. PubMed ID: 28007993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.